{
    "clinical_study": {
        "@rank": "26767", 
        "acronym": "MEOREV", 
        "arm_group": [
            {
                "arm_group_label": "Medical air", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "equimolar mixture of oxygen and nitrous oxide", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "The variety of breech presentation at term is about 3-4% of all births. Our study aims to\n      assess the value of using an equimolar mixture of oxygen and nitrous oxide. Indeed, in some\n      patients algic or relaxed, the success rate seems more important.\n\n      It's a single blind prospective randomized controlled study, comparing success rate of ECV\n      after an equimolar mixture of oxygen and nitrous oxide or placebo (medical air).\n\n      We need to include 150 patients (75 in each arm), for a period of 2 years. After ECV, we\n      will give the patient a satisfaction questionnaire. We compare the success rate of ECV as\n      primary outcome."
        }, 
        "brief_title": "Evaluation of the Efficacy and Safety of an Equimolar Mixture of Oxygen and Nitrous Oxide in External Cephalic Version (ECV)", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Breech Presentation in Pregnancy", 
        "condition_browse": {
            "mesh_term": "Breech Presentation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age \u2265 18 years\n\n          -  pregnancy at term (\u226536 weeks)\n\n          -  singleton foetus in breech or transverse presentation\n\n          -  acceptance of ECV\n\n          -  signature of informed consent\n\n        Exclusion Criteria:\n\n          -  contraindications of ECV: placenta praevia, obstacle praevia, multiple pregnancy,\n             foetal death, foetal heart rhythm disorder, lack of amniotic fluid, HIV-positive\n             patient\n\n          -  contraindications of equimolar mixture of oxygen and nitrous oxide : patient who\n             require pure oxygen ventilation, disorders of consciousness that impede the\n             cooperation of the patient, pneumothorax, pulmonary embolism, ocular surgery"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01948115", 
            "org_study_id": "RC13_0254"
        }, 
        "intervention": {
            "arm_group_label": [
                "Medical air", 
                "equimolar mixture of oxygen and nitrous oxide"
            ], 
            "description": "We need to include 150 patients for a period of 2 years. Patients will be randomized: 75 patients in each arm: 75 patients in group \"placebo\" (medical air), 75 patients in group \"treatment\" (equimolar mixture of oxygen and nitrous oxide).\nPatients will be single-blind. The ECV be started at least 3 minutes after the start of administration. The maximum time of administration of the gas will be 15 minutes. Just after ECV, we compare success rate of intervention.", 
            "intervention_name": "equimolar mixture of oxygen and nitrous oxide or medical air", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Nitrous Oxide"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Breech presentation", 
            "equimolar mixture of oxygen and nitrous oxide", 
            "external cephalic version"
        ], 
        "lastchanged_date": "February 17, 2014", 
        "location": {
            "contact": {
                "last_name": "Julie ESBELIN, Dr", 
                "phone": "02 40 08 78 17"
            }, 
            "facility": {
                "address": {
                    "city": "Nantes", 
                    "country": "France", 
                    "zip": "44093"
                }, 
                "name": "Nantes University Hospital"
            }, 
            "investigator": {
                "last_name": "Julie ESBELIN, Dr", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective Randomized Controlled Trial to Evaluate the Efficacy and Safety of an Equimolar Mixture of Oxygen and Nitrous Oxide in External Cephalic Version (ECV) in Singleton Pregnancy in Breech Presentation at Term", 
        "overall_contact": {
            "last_name": "Julie ESBELIN, Dr", 
            "phone": "02 40 08 78 17"
        }, 
        "overall_official": {
            "affiliation": "Nantes University Hospital", 
            "last_name": "Julie ESBELIN, Dr", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Success rate just after ECV between the two groups (equimolar mixture of oxygen and nitrous oxide group, and medical air group) with ultrasound.", 
            "measure": "Number of women with success after ECV", 
            "safety_issue": "No", 
            "time_frame": "20 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01948115"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Just after ECV:\npain during ECV with Visual Analogue Scale", 
                "measure": "Pain during ECV", 
                "safety_issue": "Yes", 
                "time_frame": "20 minutes"
            }, 
            {
                "description": "Just after ECV:\nFrequency of nausea / vomiting between the two groups", 
                "measure": "Frequency of nausea/vomiting", 
                "safety_issue": "Yes", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "Just after ECV:\nnumber of interrupted procedures due to pain", 
                "measure": "Number of interrupted procedures", 
                "safety_issue": "No", 
                "time_frame": "20 minutes"
            }, 
            {
                "description": "At birth:\nrate of cephalic presentation between the two groups", 
                "measure": "Number of cephalic presentation at birth", 
                "safety_issue": "No", 
                "time_frame": "2 month"
            }, 
            {
                "description": "At birth:\ncesarean rate between the two groups", 
                "measure": "Number of cesarean at birth", 
                "safety_issue": "No", 
                "time_frame": "2 month"
            }
        ], 
        "source": "Nantes University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nantes University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}